AMYRA is developing a unique enzyme combination for curative care of Celiac Disease and Non-Celiac Gluten Sensitivity (NCGS), which represent major public health issues.
AMYRA’s products have the potential to establish the standard of care and majorly impact the lives of affected people.


Malzgasse 9, 4052 Basel, Switzerland

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business